Targetable alterations in invasive pleomorphic lobular carcinoma of the breast.
Gregory M RiedlingerSonali JoshiKim M HirshfieldNicola BarnardShridar GanesanPublished in: Breast cancer research : BCR (2021)
Our results show a high frequency of ERBB2 and PIK3CA alterations in PLC and suggest all PLC should be tested for potential therapeutic targeting.